BCL2L1 and acute myeloid leukemia: We show that inhibition of Bcl-xL by small molecular inhibitor, ABT-263, or by siRNAs, triggers the rapid demise of polyploid cells in AML cell lines and primary bone marrow blasts, but not in normal, non-transformed cells.